Given the increasing evidence that depletion of Nedd9 drastically reduces migration and invasion of highly metastatic mammary tumour cells [5],[15],[25], inhibition of Nedd9 expression and/or activity represents an attractive strategy to target aggressive breast cancer cells. This evidence concerns the gene NEDD9 and breast carcinoma.